Discovering

A disciplined, highly targeted approach to discovering new cancer medicines

Go

Developing

Rigorous, definitive clinical trials based on deep biology and chemistry expertise

Go

Delivering

Committed to bringing differentiated new cancer medicines to patients

Go

Iclusig®(ponatinib)

ARIAD's first internally discovered and developed medicine

Go
       

News & Features

Latest News

9/29/14

ARIAD Presents Updated Clinical Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer

Read More

8/6/14

ARIAD Reports Second Quarter 2014 Financial Results and Development Progress

Read More

Our Corporate Brochure

A shared commitment to patients and each other. This is ARIAD.

click here for PDF

Print page Share page
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue